Proceedings/Recueil Des Communications Journal of Hepatology Année : 2024

FRI-485 CHKA, a potential target marker for early-stage metabolic dysfunction associated steatotic liver disease induced hepatocellular carcinoma with low fibrosis level: analysis by metabolomic and transcriptomic

Fatima Dahboul
Delphine Weil-Verhoeven
  • Fonction : Auteur
Vincent Di Martino
  • Fonction : Auteur
Aicha Demidem
  • Fonction : Auteur
  • PersonId : 1203012

Domaines

Fichier non déposé

Dates et versions

hal-04614847 , version 1 (17-06-2024)

Identifiants

Citer

Jihan Sun, Fatima Dahboul, Estelle Pujos-Guillot, Stéphanie Durand, Mélanie Pétéra, et al.. FRI-485 CHKA, a potential target marker for early-stage metabolic dysfunction associated steatotic liver disease induced hepatocellular carcinoma with low fibrosis level: analysis by metabolomic and transcriptomic. EASL Congress 2024, Journal of Hepatology, 80, pp.S422-S423, 2024, ⟨10.1016/S0168-8278(24)01343-6⟩. ⟨hal-04614847⟩
143 Consultations
0 Téléchargements

Altmetric

Partager

  • More